Hudson Bay Capital Management LP, 10% Owner at Akers Biosciences, Inc. (AKER), bought 191,631 shares at $2.99 ($580K) on 2019-12-09, disclosed to the SEC on 2020-01-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.99 | 50,000 | $150K | 25.8% |
| 2 | $2.97 | 30,000 | $89K | 15.4% |
| 3 | $3.05 | 6,019 | $18K | 3.2% |
| 4 | $3.10 | 26,406 | $82K | 14.1% |
| 5 | $3.10 | 26,406 | $82K | 14.1% |
| 6 | $2.98 | 20,600 |
| $61K |
| 10.6% |
| 7 | $3.02 | 6,000 | $18K | 3.1% |
| 8 | $3.07 | 5,000 | $15K | 2.6% |
| 9 | $3.03 | 3,000 | $9K | 1.6% |
| 10 | $3.07 | 7,500 | $23K | 4.0% |
| 11 | $3.08 | 2,700 | $8K | 1.4% |
| 12 | $3.02 | 8,000 | $24K | 4.2% |
| Total | $3.03 avg | 191,631 | $580K | 100% |
| Filing → |
| ZGYH | SELL | 2021-10-26 | $2.2M | — | Filing → |
| AMCI | SELL | 2020-12-01 | $1.1M | — | Filing → |
| TDAC | SELL | 2020-07-15 | $7.8M | — | Filing → |